WAT
48
-11
ROST
57
-3
OMC
50
-16
HSIC
45
5
YUM
43
-6
AZO
50
-5
F
56
-3
MLM
45
-5
EQR
54
3
CTSH
60
-3
MRK
17
-5
ORLY
60
-5
MMM
35
-5
DOV
65
-4
HSY
31
-6
STI
45
26
NOC
41
9
MSFT
48
-9
APH
65
-3
EQT
51
-3
WAT
48
-11
ROST
57
-3
OMC
50
-16
HSIC
45
5
YUM
43
-6
AZO
50
-5
F
56
-3
MLM
45
-5
EQR
54
3
CTSH
60
-3
MRK
17
-5
ORLY
60
-5
MMM
35
-5
DOV
65
-4
HSY
31
-6
STI
45
26
NOC
41
9
MSFT
48
-9
APH
65
-3
EQT
51
-3
Financhill
Back

Ivanhoe Mines Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
47

IVN.TO
Ivanhoe Mines

Last Price:
17.71
Seasonality Move:
9.9%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
47
Ivanhoe Mines (IVN.TO) is a Sell

Is Ivanhoe Mines a Buy, Sell or Hold?

  • The current Ivanhoe Mines [IVN.TO] share price is $17.71. The Score for IVN.TO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • IVN.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IVN.TO Stock Price Chart

What is Ivanhoe Mines's stock price today?

  • The Ivanhoe Mines share price today is $17.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVN.TO is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

IVN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.33 Sell
Relative Strength Index (14 RSI): 42.11 Sell
Chaikin Money Flow: -782930 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.23 - 19.59) Sell
Bollinger Bands (100): (16.89 - 19.59) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

IVN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.29 Sell
20-day SMA: 18.81 Sell
50-day SMA: 18.74 Sell
200-day SMA: 17.68 Buy
8-day EMA: 18.13 Sell
20-day EMA: 18.6 Sell
50-day EMA: 18.65 Sell
200-day EMA: 17.32 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Ivanhoe Mines Earnings Growth & IVN.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.48 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Ivanhoe Mines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):